Details for New Drug Application (NDA): 022494
✉ Email this page to a colleague
NDA 022494 describes SODIUM FLUORIDE F 18, which is a drug marketed by Nih Nci Dctd and is included in one NDA. Additional details are available on the SODIUM FLUORIDE F 18 profile page.
The generic ingredient in SODIUM FLUORIDE F 18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
The generic ingredient in SODIUM FLUORIDE F 18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
Summary for 022494
| Tradename: | SODIUM FLUORIDE F 18 |
| Applicant: | Nih Nci Dctd |
| Ingredient: | sodium fluoride f-18 |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 022494
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 10-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jan 26, 2011 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
